The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working Party
Abstract
This is an analysis of 509 patients with severe aplastic anaemia (SAA) treated in Europe between 1981 and 1986; 218 patients were treated by allogeneic bone marrow transplantation (BMT) from HLA identical sibling donors and 291 with immunosuppressive therapy (IS) with antilymphocyte globulin (ALG). The overall actuarial survival was 63% after BMT and 61% after IS therapy at 6 years. All patients fulfilled the criteria of SAA; however, most patients with a neutrophil count of <0.2 × 10 9/l also had infections and haemorrhages. Therefore a further subclassification was defined by pretreatment peripheral blood neutrophil count: very severe aplastic anaemia (vSAA) (<0.2 × 10 9/l neutrophils) and moderately severe aplastic anaemia (mSAA) (0.2‐0.5 × 10 9/l neutrophils). A Cox regression analysis showed that the only significant pre‐treatment variables were a low neutrophil count (P= 0.001) and increasing age (P= 0.05). Thus it seemed reasonabie to analyse survival data after combined stratification for neutrophils (vSAA versus mSAA) and age (cut off at 20 years). BMT was superior to IS in patients with vSAA under 20 years of age (64%v.38%;P= 0.01). IS was superior to BMT in patients with mSAA aged 20 or more (82%v.62%;P= 0.002). The two treatments gave comparable results in young patients with mSAA (BMT = 58%, IS = 62%;P= 0.1), and in older patients with vSAA (BMT = 44%. IS = 43%;P= 0.06). Overall 75/218 and 87/291 patients, given BMT or IS respectively, died. The major cause of failure in BMT patients was graft rejection (n= 22) or problems associated with graft‐versus‐host disease. For ALG patients the major problem was persistence of the aplasia with haemorrhage (n= 32) or infections (n= 46). This study indicates that over 60% of patients with SAA can be successfully treated with either BMT or IS. Overall survival does not differ in the two groups, though significant differences emerge after stratification for severity of the aplasia and age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Marrow transplantation for aplastic anemia.
Storb, R. F., Thomas, E. D., Buckner, C. D., et al. (1984) · PubMed · Cited by 136
Aplastic Anemia: Stem Cell Biology and Advances in Treatment
Gamba‐Vitalo, C. (1985) · PubMed Central · Cited by 67
Treatment of severe aplastic anemia with antilymphocyte globulin and androgens.
Gluckman, É., Devergié, A., Faille, A., et al. (1978) · PubMed · Cited by 52
Cited by
Guidelines for the diagnosis and management of adult aplastic anaemia
Killick, S. B., Bown, N., Cavenagh, J., Dokal, I., Foukaneli, T., Hill, A., Hillmen, P., Ireland, R., Kulasekararaj, A., Mufti, G., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.13853 · Cited by 749
Self-citationGuidelines for the diagnosis and management of aplastic anaemia
Marsh, J. C. W., Ball, S. E., Cavenagh, J., Darbyshire, P., Dokal, I., Gordon‐Smith, E. C., Keidan, J., Laurie, A., Martin, A., Mercieca, J., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07842.x · Cited by 560
Self-citationHow I treat acquired aplastic anemia
Bacigalupo, A. (2017) · Blood · doi:10.1182/blood-2016-08-693481 · Cited by 421
Self-citationRosenfeld, S., Kimball, J., Vining, D., & Young, N. (1995) · Blood · doi:10.1182/blood.v85.11.3058.bloodjournal85113058 · Cited by 319
Progressive Telomere Shortening in Aplastic Anemia
Ball, S. E., Gibson, F. M., Rizzo, S., Tooze, J. A., Marsh, J. C. W., & Gordon-Smith, E. C. (1998) · Blood · doi:10.1182/blood.v91.10.3582 · Cited by 290
Self-citation
Metadata
- Authors
- Bacigalupo, A., Hows, J., Gluckman, E., Nissen, C., Marsh, J., Van Lint, M. T., Congiu, M., De Planque, M. M., Ernst, P., McCann, S., Ragavashar, A., Frickhofen, N., Wursch, A., Marmont, A. M., & Gordon‐Smith, E. C.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1988-10
- Volume
- 70
- Issue
- 2
- Pages
- 177-182
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2055482423
- Cited by
- 385
- References
- 7
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working Party. https://app.cochat.ai/papers/10.1111/j.1365-2141.1988.tb02460.x
- The paper
- Bacigalupo, A., Hows, J., Gluckman, E., Nissen, C., Marsh, J., Van Lint, M. T., Congiu, M., De Planque, M. M., Ernst, P., McCann, S., Ragavashar, A., Frickhofen, N., Wursch, A., Marmont, A. M., & Gordon‐Smith, E. C. (1988). Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working Party. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.1988.tb02460.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.